Legend Biotech (LEGN) Asset Utilization Ratio (2020 - 2026)
Legend Biotech's (LEGN) quarterly Asset Utilization Ratio came in at 0.68 in Q1 2026, up 54.29% YoY from 0.44 in Q1 2025, and up 14.57% on a QoQ basis from 0.6 in Q4 2025.
Legend Biotech (LEGN) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 7 years of Asset Utilization Ratio data on file, last reported at 0.68 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 54.29% year-over-year to 0.68 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.68 (up 54.29% YoY) and the FY2025 annual result came in at 0.6, up 69.56% from the prior year.
- Asset Utilization Ratio grew to 0.68 in Q1 2026, from 0.6 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 45.22 in Q3 2024 to a low of 0.08 in Q1 2023.
- A 5-year average of 12.9 and a median of 0.51 in 2025 frame the typical range for Asset Utilization Ratio.
- The widest YoY moves for Asset Utilization Ratio: up 54004.99% in 2024, down 99.15% in 2024.
- Tracing LEGN's Asset Utilization Ratio over 5 years: stood at 0.12 in 2022, then jumped by 36951.55% to 43.21 in 2023, then tumbled by 99.15% to 0.37 in 2024, then jumped by 62.07% to 0.6 in 2025, then gained by 14.57% to 0.68 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.68 (Q1 2026), 0.6 (Q4 2025), and 0.53 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | 0.76 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.76 |
| Mar 31, 2026 | 0.68 |
| Dec 31, 2025 | 0.60 |
| Sep 30, 2025 | 0.53 |
| Jun 30, 2025 | 0.48 |
| Mar 31, 2025 | 0.44 |
| Dec 31, 2024 | 0.37 |
| Sep 30, 2024 | 45.22 |
| Jun 30, 2024 | 44.69 |
| Mar 31, 2024 | 44.00 |
| Dec 31, 2023 | 43.21 |
| Sep 30, 2023 | 0.12 |
| Jun 30, 2023 | 0.10 |
| Mar 31, 2023 | 0.08 |
| Mar 31, 2022 | 0.12 |
| Dec 31, 2021 | 0.09 |
| Sep 30, 2021 | 0.11 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.00 |